Patents by Inventor Odile Ramaen

Odile Ramaen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11920178
    Abstract: The present invention relates to the use of type III polyketide synthases of bacteria, such as actinomycete bacteria, as phloroglucinol synthases. The present invention also relates to the isolated nucleic acid molecules encoding these type III polyketide synthases, and also to the vectors and the host cells comprising such nucleic acid molecules. The present invention also relates to methods for producing phloroglucinol.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: March 5, 2024
    Assignee: COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
    Inventors: Vincent Lafaquiere, Odile Ramaen, Dominique Louis
  • Patent number: 11512293
    Abstract: Methods for producing phloroglucinol as well as methods of using type III polyketide synthases as phloroglucinol synthases, in particular the type III polyketide synthases of algae, such as eukaryotic ochrophyte algae, are described herein. In addition, polypeptides that have phloroglucinol synthase activity, the isolated nucleic acid molecules encoding these type III polyketide synthases, and the vectors and the host cells comprising such nucleic acid molecules are also described.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: November 29, 2022
    Assignee: COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
    Inventors: Vincent Lafaquiere, Odile Ramaen, Dominique Louis
  • Publication number: 20220098626
    Abstract: The present invention relates to a living cell, preferably a host cell, that is phloroglucinol resistant, said host cell being characterized in that it overexpresses a polypeptide selected from (i) transmembrane transporters of the ABC family, in particular transmembrane transporters of the PDR subfamily, (ii) transcription factors which control the expression of the transmembrane transporters of the PDR subfamily, and (iii) transmembrane transporters of the MFS family; preferably a polypeptide selected from SNQ2, STE6, PDR3, AQR1, DTR1, FLR1, QDR1, YHK8 and ATR1; and more preferably the SNQ2 transporter. The present invention also relates to a method for producing a phloroglucinol-resistant recombinant host cell. The present invention also relates to a method for producing phloroglucinol.
    Type: Application
    Filed: February 5, 2020
    Publication date: March 31, 2022
    Inventors: ODILE RAMAEN, VINCENT LAFAQUIERE, DOMINIQUE LOUIS
  • Publication number: 20210147884
    Abstract: The present invention relates to the use of type III polyketide synthases of bacteria, such as actinomycete bacteria, as phloroglucinol synthases. The present invention also relates to the isolated nucleic acid molecules encoding these type III polyketide synthases, and also to the vectors and the host cells comprising such nucleic acid molecules. The present invention also relates to methods for producing phloroglucinol.
    Type: Application
    Filed: June 29, 2018
    Publication date: May 20, 2021
    Inventors: VINCENT LAFAQUIERE, ODILE RAMAEN, DOMINIQUE LOUIS
  • Publication number: 20200123508
    Abstract: Methods for producing phloroglucinol as well as methods of using type III polyketide synthases as phloroglucinol synthases, in particular the type III polyketide synthases of algae, such as eukaryotic ochrophyte algae, are described herein. In addition, polypeptides that have phloroglucinol synthase activity, the isolated nucleic acid molecules encoding these type III polyketide synthases, and the vectors and the host cells comprising such nucleic acid molecules are also described.
    Type: Application
    Filed: June 29, 2018
    Publication date: April 23, 2020
    Inventors: VINCENT LAFAQUIERE, ODILE RAMAEN, DOMINIQUE LOUIS
  • Patent number: 10519472
    Abstract: A cell may include heterologous polynucleotides encoding a multienzyme complex involved in the metabolic pathway of phenylpropanoids and biosynthesis of a vanilloid or a hydroxybenzaldehyde precursor thereof, which multienzyme complex comprises enzymes for the biosynthesis of coumaric acid and a crotonase.
    Type: Grant
    Filed: December 30, 2013
    Date of Patent: December 31, 2019
    Assignee: RHODIA OPERATIONS
    Inventors: Odile Ramaen, Vincent Sauveplane, Rudy Pandjaitan
  • Patent number: 10006060
    Abstract: The present invention relates to methods for producing vanilloid compounds in a recombinant host, and in particular for converting a protocatechuic aldehyde into a substantially pure vanilloid. It further relates to novel yeast strains that are suitable for producing such vanilloid compounds.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: June 26, 2018
    Assignee: RHODIA OPERATIONS
    Inventors: Odile Ramaen, Rudy Pandjaitan, Mirjana Gelo-Pujic
  • Publication number: 20170114373
    Abstract: The present invention relates to methods for producing vanilloid compounds in a recombinant host, and in particular for converting a protocatechuic aldehyde into a substantially pure vanilloid. It further relates to novel yeast strains that are suitable for producing such vanilloid compounds.
    Type: Application
    Filed: June 17, 2015
    Publication date: April 27, 2017
    Inventors: Odile Ramaen, Rudy Pandjaitan, Mirjana Gelo-Pujic
  • Publication number: 20150322465
    Abstract: A cell may include heterologous polynucleotides encoding a multienzyme complex involved in the metabolic pathway of phenylpropanoids and biosynthesis of a vanilloid or a hydroxybenzaldehyde precursor thereof, which multienzyme complex comprises enzymes for the biosynthesis of coumaric acid and a crotonase.
    Type: Application
    Filed: December 30, 2013
    Publication date: November 12, 2015
    Applicant: Rhodia Operations
    Inventors: Odile Ramaen, Vincent Sauveplane, Rudy Pandjaitan